Moreover, the highest HR was detected in the correlation between SPINT1 expression and DMFS in HER2+ patients (HR = 7.74, P = 0.0011), suggesting that SPINT1 influenced patient clinical outcomes, possibly by affecting tumor metastasis, particularly in the HER2+ subgroup. This evidence concerns the gene ERBB2 and neoplasm.